WBA
50
2
LRCX
49
7
FMC
31
-5
RRC
65
2
SWKS
39
2
CAT
40
-2
CFG
40
10
ES
38
2
ROP
59
2
MTB
59
3
AEP
66
-3
EXC
69
-3
SLG
41
2
FFIV
57
3
VRSK
63
-3
MCK
74
-4
PX
42
2
SWK
34
-12
CHRW
50
-3
PFE
37
14
WBA
50
2
LRCX
49
7
FMC
31
-5
RRC
65
2
SWKS
39
2
CAT
40
-2
CFG
40
10
ES
38
2
ROP
59
2
MTB
59
3
AEP
66
-3
EXC
69
-3
SLG
41
2
FFIV
57
3
VRSK
63
-3
MCK
74
-4
PX
42
2
SWK
34
-12
CHRW
50
-3
PFE
37
14
Financhill
Back

Renaissance IPO ETF Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
40

IPO
Renaissance IPO ETF

Last Price:
$37.51
Seasonality Move:
1.54%
Buy
54

DRUG
Bright Minds Biosciences

Last Price:
$36.00
Seasonality Move:
-28.52%
Sell
40
Renaissance IPO ETF (IPO) is a Sell

Is Renaissance IPO ETF a Buy, Sell or Hold?

  • The current Renaissance IPO ETF [IPO] share price is $38.56. The Score for IPO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • IPO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Bright Minds Biosciences (DRUG) is a Buy

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $36.25. The Score for DRUG is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IPO Stock Price Chart

What is Renaissance IPO ETF's stock price today?

  • The Renaissance IPO ETF share price today is $38.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPO is experiencing slight selling pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $36.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

IPO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.92 Sell
Relative Strength Index (14 RSI): 31.07 Sell
Chaikin Money Flow: -356 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.59 - 47.07) Sell
Bollinger Bands (100): (42.99 - 46.95) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.82 Sell
Relative Strength Index (14 RSI): 50.3 Buy
Chaikin Money Flow: 47724 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.85 - 42.25) Sell
Bollinger Bands (100): (33.67 - 45.15) Sell

IPO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.84 Sell
20-day SMA: 42.91 Sell
50-day SMA: 44.59 Sell
200-day SMA: 42.82 Sell
8-day EMA: 39.85 Sell
20-day EMA: 42.02 Sell
50-day EMA: 43.81 Sell
200-day EMA: 42.71 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.16 Buy
20-day SMA: 37.2 Sell
50-day SMA: 37.07 Sell
200-day SMA: 20.27 Buy
8-day EMA: 35.28 Buy
20-day EMA: 36.12 Buy
50-day EMA: 36.52 Sell
200-day EMA: 24.96 Buy

Renaissance IPO ETF Earnings Growth & IPO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.85 per share, and a decrease next year of $2.17 per share.

Renaissance IPO ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):